Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Spin Labels | 53 | 2024 | 336 | 6.320 |
Why?
|
Cerebrovascular Circulation | 68 | 2024 | 2733 | 5.260 |
Why?
|
Magnetic Resonance Imaging | 176 | 2024 | 36290 | 3.860 |
Why?
|
Magnetic Resonance Angiography | 20 | 2022 | 1431 | 3.480 |
Why?
|
Myelin Sheath | 13 | 2022 | 652 | 2.500 |
Why?
|
Image Processing, Computer-Assisted | 61 | 2024 | 8950 | 2.470 |
Why?
|
Image Enhancement | 33 | 2018 | 2881 | 2.340 |
Why?
|
Arteries | 15 | 2022 | 1126 | 2.340 |
Why?
|
Brain | 93 | 2024 | 26951 | 2.240 |
Why?
|
Perfusion Imaging | 10 | 2023 | 196 | 2.050 |
Why?
|
Image Interpretation, Computer-Assisted | 18 | 2017 | 3340 | 1.510 |
Why?
|
Blood Flow Velocity | 18 | 2018 | 1377 | 1.480 |
Why?
|
Brain Mapping | 41 | 2024 | 6568 | 1.450 |
Why?
|
Delirium | 18 | 2024 | 1663 | 1.340 |
Why?
|
Imaging, Three-Dimensional | 11 | 2023 | 4048 | 1.230 |
Why?
|
Cerebral Arteries | 6 | 2021 | 493 | 1.200 |
Why?
|
Algorithms | 33 | 2024 | 13981 | 1.090 |
Why?
|
Abdomen | 4 | 2019 | 1130 | 1.060 |
Why?
|
Perfusion | 17 | 2023 | 1376 | 1.000 |
Why?
|
Artifacts | 16 | 2020 | 1898 | 0.930 |
Why?
|
Cerebral Cortex | 21 | 2024 | 5761 | 0.870 |
Why?
|
Signal Processing, Computer-Assisted | 4 | 2018 | 1489 | 0.860 |
Why?
|
Kidney Neoplasms | 15 | 2020 | 4312 | 0.770 |
Why?
|
Echo-Planar Imaging | 10 | 2019 | 657 | 0.750 |
Why?
|
Alzheimer Disease | 14 | 2024 | 8547 | 0.730 |
Why?
|
Nerve Fibers, Myelinated | 7 | 2014 | 952 | 0.730 |
Why?
|
Rest | 8 | 2024 | 914 | 0.690 |
Why?
|
Kidney | 7 | 2019 | 7064 | 0.690 |
Why?
|
Diffusion Magnetic Resonance Imaging | 8 | 2018 | 2782 | 0.650 |
Why?
|
Carcinoma, Renal Cell | 14 | 2020 | 3218 | 0.640 |
Why?
|
Regional Blood Flow | 14 | 2018 | 1490 | 0.630 |
Why?
|
Cerebral Angiography | 3 | 2016 | 1274 | 0.610 |
Why?
|
Spinal Cord | 11 | 2022 | 1817 | 0.600 |
Why?
|
Choroid Plexus | 1 | 2020 | 237 | 0.590 |
Why?
|
Sensitivity and Specificity | 28 | 2019 | 14660 | 0.550 |
Why?
|
Phantoms, Imaging | 13 | 2019 | 2512 | 0.540 |
Why?
|
Reproducibility of Results | 30 | 2023 | 20080 | 0.540 |
Why?
|
Aorta, Abdominal | 1 | 2018 | 625 | 0.510 |
Why?
|
Motion | 7 | 2022 | 779 | 0.500 |
Why?
|
Pancreas | 2 | 2019 | 1677 | 0.490 |
Why?
|
Humans | 221 | 2024 | 760621 | 0.470 |
Why?
|
Adult | 111 | 2024 | 219994 | 0.460 |
Why?
|
Male | 155 | 2024 | 359744 | 0.450 |
Why?
|
Cerebrospinal Fluid | 3 | 2016 | 544 | 0.450 |
Why?
|
Dacarbazine | 1 | 2016 | 560 | 0.450 |
Why?
|
Respiratory-Gated Imaging Techniques | 2 | 2015 | 75 | 0.440 |
Why?
|
Subtraction Technique | 3 | 2011 | 510 | 0.430 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2016 | 618 | 0.420 |
Why?
|
Female | 148 | 2024 | 391270 | 0.420 |
Why?
|
Postoperative Complications | 17 | 2024 | 15697 | 0.420 |
Why?
|
Blood Volume Determination | 1 | 2012 | 41 | 0.410 |
Why?
|
Contrast Media | 10 | 2022 | 5305 | 0.400 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 4 | 2014 | 133 | 0.400 |
Why?
|
Young Adult | 35 | 2022 | 58741 | 0.400 |
Why?
|
Abdominal Neoplasms | 1 | 2013 | 286 | 0.390 |
Why?
|
tert-Butyl Alcohol | 1 | 2011 | 3 | 0.390 |
Why?
|
Functional Laterality | 19 | 2012 | 2253 | 0.380 |
Why?
|
Whole Body Imaging | 1 | 2013 | 278 | 0.380 |
Why?
|
Glioma | 3 | 2016 | 3420 | 0.370 |
Why?
|
Protons | 5 | 2023 | 1114 | 0.350 |
Why?
|
Angiography, Digital Subtraction | 1 | 2010 | 334 | 0.330 |
Why?
|
Nerve Net | 8 | 2024 | 2261 | 0.330 |
Why?
|
Renal Artery | 2 | 2019 | 370 | 0.320 |
Why?
|
Atrophy | 9 | 2024 | 1627 | 0.320 |
Why?
|
Immune Reconstitution Inflammatory Syndrome | 3 | 2013 | 61 | 0.310 |
Why?
|
Lewy Body Disease | 1 | 2011 | 252 | 0.310 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2011 | 269 | 0.310 |
Why?
|
Retinal Vessels | 2 | 2011 | 836 | 0.300 |
Why?
|
Posture | 2 | 2010 | 953 | 0.300 |
Why?
|
Postural Balance | 2 | 2010 | 617 | 0.290 |
Why?
|
Rheology | 1 | 2008 | 348 | 0.290 |
Why?
|
Glucose | 1 | 2019 | 4351 | 0.290 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 5 | 2016 | 666 | 0.290 |
Why?
|
Respiration | 3 | 2018 | 1654 | 0.280 |
Why?
|
Hippocampus | 6 | 2023 | 3738 | 0.270 |
Why?
|
Neurology | 1 | 2014 | 779 | 0.260 |
Why?
|
Benzenesulfonates | 3 | 2011 | 165 | 0.260 |
Why?
|
Temporal Lobe | 15 | 2003 | 1688 | 0.260 |
Why?
|
Somatosensory Cortex | 3 | 2002 | 511 | 0.260 |
Why?
|
Cerebrovascular Disorders | 7 | 2009 | 1501 | 0.250 |
Why?
|
Blood Circulation | 1 | 2006 | 249 | 0.240 |
Why?
|
Fibrosis | 1 | 2011 | 2042 | 0.230 |
Why?
|
Gadolinium DTPA | 2 | 2009 | 823 | 0.230 |
Why?
|
Aged | 63 | 2024 | 169152 | 0.220 |
Why?
|
Verbal Behavior | 4 | 2011 | 335 | 0.210 |
Why?
|
Neovascularization, Pathologic | 6 | 2019 | 2640 | 0.210 |
Why?
|
Dementia | 4 | 2017 | 2649 | 0.210 |
Why?
|
Cerebral Infarction | 5 | 2010 | 982 | 0.210 |
Why?
|
Models, Theoretical | 8 | 2023 | 3562 | 0.200 |
Why?
|
Middle Aged | 60 | 2020 | 220352 | 0.200 |
Why?
|
C-Reactive Protein | 4 | 2019 | 3839 | 0.200 |
Why?
|
Attention | 5 | 2013 | 2387 | 0.200 |
Why?
|
Speech Perception | 4 | 2003 | 505 | 0.190 |
Why?
|
Epilepsy, Temporal Lobe | 6 | 2001 | 387 | 0.190 |
Why?
|
Feasibility Studies | 7 | 2020 | 5201 | 0.190 |
Why?
|
Membrane Lipids | 1 | 2022 | 251 | 0.190 |
Why?
|
Frontal Lobe | 8 | 2011 | 1420 | 0.190 |
Why?
|
Oxygen | 7 | 2011 | 4193 | 0.180 |
Why?
|
Reference Values | 10 | 2009 | 4925 | 0.180 |
Why?
|
Music | 3 | 2012 | 245 | 0.180 |
Why?
|
Pyridines | 5 | 2011 | 2879 | 0.180 |
Why?
|
Computer Simulation | 5 | 2018 | 6218 | 0.180 |
Why?
|
Radio Waves | 4 | 2021 | 250 | 0.180 |
Why?
|
Brain Ischemia | 5 | 2012 | 3127 | 0.180 |
Why?
|
Demyelinating Diseases | 1 | 2022 | 351 | 0.170 |
Why?
|
Amides | 2 | 2014 | 448 | 0.170 |
Why?
|
Memory | 8 | 2005 | 2179 | 0.170 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 2 | 2018 | 556 | 0.170 |
Why?
|
Magnetics | 3 | 2018 | 600 | 0.170 |
Why?
|
Aging | 10 | 2016 | 8651 | 0.170 |
Why?
|
Diffusion Tensor Imaging | 4 | 2018 | 2385 | 0.170 |
Why?
|
Pelvis | 1 | 2004 | 743 | 0.170 |
Why?
|
Prospective Studies | 19 | 2021 | 54303 | 0.160 |
Why?
|
Spin Trapping | 1 | 1998 | 4 | 0.160 |
Why?
|
Early Detection of Cancer | 1 | 2013 | 3202 | 0.160 |
Why?
|
Visual Cortex | 3 | 2006 | 1089 | 0.160 |
Why?
|
Cognition Disorders | 8 | 2016 | 3976 | 0.160 |
Why?
|
Aged, 80 and over | 20 | 2024 | 58995 | 0.160 |
Why?
|
Personality | 3 | 2013 | 552 | 0.160 |
Why?
|
Pyrroles | 3 | 2016 | 1137 | 0.150 |
Why?
|
Magnetic Resonance Spectroscopy | 7 | 2016 | 3765 | 0.150 |
Why?
|
Macromolecular Substances | 2 | 2023 | 1433 | 0.150 |
Why?
|
Cytokines | 3 | 2019 | 7343 | 0.150 |
Why?
|
Brain Neoplasms | 5 | 2014 | 8986 | 0.150 |
Why?
|
Sulfonamides | 2 | 2020 | 1977 | 0.140 |
Why?
|
Language | 2 | 2003 | 1533 | 0.140 |
Why?
|
Sphingosine | 2 | 2019 | 308 | 0.140 |
Why?
|
Neuropsychological Tests | 11 | 2020 | 7021 | 0.140 |
Why?
|
Practice Guidelines as Topic | 1 | 2014 | 7475 | 0.140 |
Why?
|
Lysophospholipids | 2 | 2019 | 339 | 0.140 |
Why?
|
Electromagnetic Fields | 1 | 1998 | 296 | 0.140 |
Why?
|
Calibration | 2 | 2011 | 816 | 0.130 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2019 | 544 | 0.130 |
Why?
|
Neural Pathways | 5 | 2019 | 3040 | 0.130 |
Why?
|
Nephrology | 1 | 2019 | 263 | 0.130 |
Why?
|
Anatomy, Cross-Sectional | 2 | 2011 | 141 | 0.130 |
Why?
|
Thrombolytic Therapy | 1 | 2005 | 2108 | 0.130 |
Why?
|
Activin Receptors, Type II | 1 | 2016 | 124 | 0.130 |
Why?
|
Reading | 4 | 2007 | 529 | 0.130 |
Why?
|
Kidney Cortex | 1 | 2015 | 169 | 0.130 |
Why?
|
Angiogenesis Inhibitors | 5 | 2019 | 2049 | 0.130 |
Why?
|
Brain Damage, Chronic | 1 | 1996 | 267 | 0.130 |
Why?
|
Protein Kinase Inhibitors | 4 | 2020 | 5643 | 0.130 |
Why?
|
Tracheobronchomalacia | 1 | 2017 | 131 | 0.130 |
Why?
|
Cardiac-Gated Imaging Techniques | 1 | 2016 | 140 | 0.120 |
Why?
|
Multiple Sclerosis | 4 | 2011 | 3204 | 0.120 |
Why?
|
Pyruvic Acid | 1 | 2015 | 195 | 0.120 |
Why?
|
Cognition | 9 | 2011 | 6957 | 0.120 |
Why?
|
Central Nervous System | 2 | 2017 | 1334 | 0.120 |
Why?
|
Facial Expression | 3 | 2003 | 508 | 0.120 |
Why?
|
Aphasia | 1 | 2016 | 192 | 0.120 |
Why?
|
Hand | 2 | 1999 | 903 | 0.120 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2016 | 461 | 0.120 |
Why?
|
Carbon Isotopes | 2 | 2015 | 459 | 0.120 |
Why?
|
Cerebellum | 3 | 2010 | 1496 | 0.120 |
Why?
|
Lumbar Vertebrae | 1 | 2004 | 1868 | 0.120 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 4 | 2011 | 1067 | 0.120 |
Why?
|
Phthalazines | 2 | 2008 | 383 | 0.120 |
Why?
|
Cephalometry | 1 | 2016 | 382 | 0.110 |
Why?
|
Stroke | 5 | 2010 | 9962 | 0.110 |
Why?
|
Bone Marrow | 1 | 2004 | 2912 | 0.110 |
Why?
|
Mice, Nude | 6 | 2019 | 3607 | 0.110 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2016 | 632 | 0.110 |
Why?
|
European Union | 1 | 2014 | 157 | 0.110 |
Why?
|
Recovery of Function | 2 | 2016 | 2985 | 0.110 |
Why?
|
Biological Products | 1 | 2022 | 916 | 0.110 |
Why?
|
Pattern Recognition, Visual | 4 | 2003 | 810 | 0.110 |
Why?
|
Hemorrhage | 2 | 2005 | 3600 | 0.110 |
Why?
|
Emotions | 5 | 2006 | 2734 | 0.110 |
Why?
|
Alanine | 1 | 2015 | 606 | 0.110 |
Why?
|
Time Factors | 8 | 2024 | 40165 | 0.110 |
Why?
|
Hot Temperature | 2 | 2018 | 1435 | 0.100 |
Why?
|
Physical Stimulation | 3 | 2006 | 518 | 0.100 |
Why?
|
Mice, Inbred C57BL | 8 | 2022 | 22023 | 0.100 |
Why?
|
Niacinamide | 4 | 2021 | 414 | 0.100 |
Why?
|
Microscopy, Fluorescence | 1 | 2019 | 2651 | 0.100 |
Why?
|
Motor Activity | 2 | 2021 | 2687 | 0.100 |
Why?
|
Parkinson Disease | 4 | 2014 | 2859 | 0.100 |
Why?
|
Individuality | 1 | 2013 | 300 | 0.100 |
Why?
|
Corpus Callosum | 1 | 2016 | 749 | 0.100 |
Why?
|
Trachea | 1 | 2017 | 1082 | 0.100 |
Why?
|
Central Nervous System Stimulants | 2 | 2012 | 1174 | 0.100 |
Why?
|
Brain Diseases | 3 | 2010 | 1540 | 0.090 |
Why?
|
Appetite | 1 | 2013 | 247 | 0.090 |
Why?
|
Skull | 1 | 2016 | 815 | 0.090 |
Why?
|
Propylamines | 1 | 2012 | 161 | 0.090 |
Why?
|
Boston | 2 | 2022 | 9280 | 0.090 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2013 | 324 | 0.090 |
Why?
|
Species Specificity | 1 | 2015 | 2418 | 0.090 |
Why?
|
Adenoma, Oxyphilic | 1 | 2012 | 148 | 0.090 |
Why?
|
Mental Recall | 2 | 2011 | 1206 | 0.090 |
Why?
|
Brain Injuries | 3 | 2000 | 2044 | 0.090 |
Why?
|
Fourier Analysis | 3 | 2017 | 439 | 0.090 |
Why?
|
Phenylurea Compounds | 4 | 2021 | 529 | 0.090 |
Why?
|
Organ Size | 3 | 2016 | 2254 | 0.090 |
Why?
|
Glycemic Index | 1 | 2013 | 396 | 0.090 |
Why?
|
Blood Volume | 1 | 2012 | 550 | 0.090 |
Why?
|
Adrenergic Uptake Inhibitors | 1 | 2012 | 186 | 0.090 |
Why?
|
Analysis of Variance | 8 | 2012 | 6238 | 0.090 |
Why?
|
Heptanoic Acids | 1 | 2012 | 347 | 0.090 |
Why?
|
Animals | 25 | 2022 | 167963 | 0.090 |
Why?
|
Haloperidol | 1 | 2012 | 389 | 0.090 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2017 | 1046 | 0.090 |
Why?
|
Neoplasms, Experimental | 1 | 2015 | 1229 | 0.090 |
Why?
|
Lactic Acid | 1 | 2015 | 1134 | 0.090 |
Why?
|
Hemodynamics | 1 | 2021 | 4174 | 0.090 |
Why?
|
Cyclooxygenase 2 | 1 | 2013 | 599 | 0.090 |
Why?
|
Cell Membrane | 1 | 2019 | 3682 | 0.090 |
Why?
|
Xenograft Model Antitumor Assays | 5 | 2019 | 3584 | 0.090 |
Why?
|
Hypercapnia | 1 | 2011 | 261 | 0.090 |
Why?
|
Heterocyclic Compounds | 1 | 2011 | 247 | 0.090 |
Why?
|
Auditory Perception | 2 | 2012 | 580 | 0.090 |
Why?
|
Pitch Discrimination | 1 | 2009 | 29 | 0.090 |
Why?
|
Diagnostic Imaging | 3 | 2014 | 3527 | 0.080 |
Why?
|
Water | 3 | 2018 | 1407 | 0.080 |
Why?
|
Mice | 15 | 2022 | 81208 | 0.080 |
Why?
|
Liver Neoplasms | 2 | 2021 | 4319 | 0.080 |
Why?
|
Hyperoxia | 1 | 2011 | 250 | 0.080 |
Why?
|
Antineoplastic Agents | 6 | 2015 | 13630 | 0.080 |
Why?
|
Cholinesterase Inhibitors | 1 | 2011 | 238 | 0.080 |
Why?
|
Electrodes, Implanted | 1 | 2014 | 833 | 0.080 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2021 | 2299 | 0.080 |
Why?
|
Psychophysics | 1 | 2009 | 289 | 0.080 |
Why?
|
Models, Neurological | 2 | 2015 | 1758 | 0.080 |
Why?
|
Basal Ganglia | 1 | 2011 | 552 | 0.080 |
Why?
|
Amygdala | 3 | 2013 | 1351 | 0.080 |
Why?
|
Quinolones | 1 | 2012 | 377 | 0.080 |
Why?
|
Rats, Wistar | 2 | 2011 | 1850 | 0.080 |
Why?
|
Indoles | 2 | 2016 | 1829 | 0.080 |
Why?
|
Brain Waves | 1 | 2012 | 401 | 0.080 |
Why?
|
Pyrimidines | 1 | 2020 | 3016 | 0.080 |
Why?
|
Vascular Resistance | 1 | 2011 | 933 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2015 | 5253 | 0.080 |
Why?
|
Pyramidal Tracts | 1 | 2010 | 250 | 0.080 |
Why?
|
Preoperative Care | 2 | 2016 | 2256 | 0.080 |
Why?
|
Education | 1 | 2011 | 534 | 0.070 |
Why?
|
Catheter Ablation | 1 | 2021 | 2758 | 0.070 |
Why?
|
Proteomics | 2 | 2019 | 3817 | 0.070 |
Why?
|
Task Performance and Analysis | 1 | 2012 | 759 | 0.070 |
Why?
|
Disease Progression | 6 | 2019 | 13502 | 0.070 |
Why?
|
Periventricular Nodular Heterotopia | 1 | 2007 | 53 | 0.070 |
Why?
|
Reperfusion Injury | 2 | 2005 | 1023 | 0.070 |
Why?
|
Methylphenidate | 1 | 2012 | 488 | 0.070 |
Why?
|
Cell Line, Tumor | 8 | 2019 | 16939 | 0.070 |
Why?
|
Research Design | 3 | 2017 | 6180 | 0.070 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2012 | 622 | 0.070 |
Why?
|
Organometallic Compounds | 1 | 2011 | 662 | 0.070 |
Why?
|
Carcinoma, Papillary | 1 | 2012 | 785 | 0.070 |
Why?
|
Indazoles | 2 | 2020 | 302 | 0.070 |
Why?
|
Acoustic Stimulation | 3 | 2009 | 1232 | 0.070 |
Why?
|
Massachusetts | 3 | 2019 | 8803 | 0.070 |
Why?
|
Tumor Burden | 3 | 2019 | 1895 | 0.070 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2011 | 2502 | 0.070 |
Why?
|
Reward | 1 | 2013 | 963 | 0.070 |
Why?
|
Dyslexia | 1 | 2007 | 208 | 0.070 |
Why?
|
Delphi Technique | 2 | 2019 | 829 | 0.070 |
Why?
|
Electric Stimulation | 1 | 2011 | 1735 | 0.070 |
Why?
|
Vasoconstriction | 1 | 2009 | 593 | 0.070 |
Why?
|
Gadolinium | 1 | 2011 | 959 | 0.070 |
Why?
|
Child Development | 1 | 2017 | 2285 | 0.060 |
Why?
|
Positron-Emission Tomography | 4 | 2011 | 6465 | 0.060 |
Why?
|
Adolescent | 19 | 2017 | 87810 | 0.060 |
Why?
|
Psychomotor Performance | 3 | 2010 | 1878 | 0.060 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2009 | 485 | 0.060 |
Why?
|
Space Perception | 2 | 2000 | 464 | 0.060 |
Why?
|
Deep Brain Stimulation | 1 | 2014 | 820 | 0.060 |
Why?
|
Deafness | 1 | 2009 | 457 | 0.060 |
Why?
|
Cell Adhesion Molecules | 1 | 2011 | 1602 | 0.060 |
Why?
|
Rats | 6 | 2019 | 23711 | 0.060 |
Why?
|
Respiratory Mechanics | 1 | 2009 | 699 | 0.060 |
Why?
|
Feedback | 1 | 2009 | 791 | 0.060 |
Why?
|
Severity of Illness Index | 9 | 2017 | 15840 | 0.060 |
Why?
|
Hemorheology | 1 | 2005 | 144 | 0.060 |
Why?
|
Electron Spin Resonance Spectroscopy | 1 | 2005 | 162 | 0.060 |
Why?
|
Follow-Up Studies | 8 | 2019 | 39261 | 0.060 |
Why?
|
Vasodilation | 1 | 2009 | 962 | 0.060 |
Why?
|
Cross-Sectional Studies | 6 | 2016 | 25942 | 0.060 |
Why?
|
Carotid Stenosis | 2 | 2004 | 878 | 0.060 |
Why?
|
Lung Neoplasms | 2 | 2006 | 13262 | 0.060 |
Why?
|
Permeability | 1 | 2006 | 719 | 0.060 |
Why?
|
Recruitment, Neurophysiological | 1 | 2003 | 33 | 0.060 |
Why?
|
Reperfusion | 1 | 2005 | 271 | 0.060 |
Why?
|
Survival Analysis | 1 | 2016 | 10182 | 0.060 |
Why?
|
Longitudinal Studies | 5 | 2017 | 14495 | 0.060 |
Why?
|
Risk | 3 | 2017 | 9631 | 0.050 |
Why?
|
Affect | 2 | 2019 | 1480 | 0.050 |
Why?
|
Cluster Analysis | 2 | 2024 | 2698 | 0.050 |
Why?
|
Hepatitis C, Chronic | 1 | 2011 | 1031 | 0.050 |
Why?
|
Aphasia, Broca | 1 | 2003 | 52 | 0.050 |
Why?
|
Cuprizone | 1 | 2022 | 12 | 0.050 |
Why?
|
Body Temperature | 1 | 2006 | 777 | 0.050 |
Why?
|
Psychosurgery | 2 | 2001 | 86 | 0.050 |
Why?
|
Databases as Topic | 1 | 2005 | 474 | 0.050 |
Why?
|
Glomerular Filtration Rate | 1 | 2011 | 2180 | 0.050 |
Why?
|
Gyrus Cinguli | 4 | 2019 | 1114 | 0.050 |
Why?
|
Problem Solving | 2 | 2002 | 440 | 0.050 |
Why?
|
Seizures | 2 | 2014 | 2917 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2016 | 8515 | 0.050 |
Why?
|
Pyrazoles | 1 | 2013 | 1999 | 0.050 |
Why?
|
Bipolar Disorder | 1 | 2019 | 5078 | 0.050 |
Why?
|
Reaction Time | 3 | 2003 | 2075 | 0.050 |
Why?
|
Patient Readmission | 1 | 2016 | 3323 | 0.050 |
Why?
|
Alcoholism | 1 | 2013 | 1961 | 0.050 |
Why?
|
Language Disorders | 1 | 2003 | 138 | 0.050 |
Why?
|
Epilepsies, Partial | 2 | 1996 | 430 | 0.050 |
Why?
|
Mathematical Computing | 1 | 2002 | 143 | 0.050 |
Why?
|
Blood Pressure | 4 | 2012 | 8525 | 0.050 |
Why?
|
Antibodies, Monoclonal | 2 | 2019 | 9185 | 0.050 |
Why?
|
Social Perception | 1 | 2005 | 431 | 0.050 |
Why?
|
Neoplasm Staging | 1 | 2016 | 11152 | 0.050 |
Why?
|
Anemia, Sickle Cell | 1 | 2010 | 1056 | 0.050 |
Why?
|
Neurologic Examination | 3 | 2012 | 916 | 0.050 |
Why?
|
Motor Skills | 1 | 2005 | 520 | 0.050 |
Why?
|
Fingers | 2 | 2021 | 506 | 0.050 |
Why?
|
Memory, Short-Term | 2 | 2013 | 978 | 0.050 |
Why?
|
Executive Function | 1 | 2010 | 1374 | 0.050 |
Why?
|
Vocabulary | 1 | 2002 | 165 | 0.050 |
Why?
|
Piperazines | 1 | 2012 | 2525 | 0.050 |
Why?
|
Arousal | 3 | 2002 | 1157 | 0.050 |
Why?
|
Anisotropy | 2 | 2018 | 1278 | 0.050 |
Why?
|
Photic Stimulation | 4 | 2010 | 1967 | 0.050 |
Why?
|
Pancreatic Neoplasms | 1 | 2018 | 5351 | 0.050 |
Why?
|
Coma, Post-Head Injury | 1 | 2000 | 21 | 0.050 |
Why?
|
Motivation | 2 | 2008 | 1993 | 0.050 |
Why?
|
Ischemic Attack, Transient | 2 | 2004 | 901 | 0.050 |
Why?
|
Neuronal Plasticity | 2 | 2010 | 1430 | 0.040 |
Why?
|
Lung | 2 | 1999 | 9994 | 0.040 |
Why?
|
Muscle, Skeletal | 1 | 2015 | 4925 | 0.040 |
Why?
|
Diffuse Axonal Injury | 1 | 2000 | 49 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2019 | 3804 | 0.040 |
Why?
|
Blood-Brain Barrier | 1 | 2006 | 1019 | 0.040 |
Why?
|
Neurocutaneous Syndromes | 1 | 2000 | 53 | 0.040 |
Why?
|
Amobarbital | 1 | 1999 | 43 | 0.040 |
Why?
|
Axons | 2 | 2019 | 1673 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2011 | 12293 | 0.040 |
Why?
|
Consensus | 2 | 2019 | 3113 | 0.040 |
Why?
|
Dominance, Cerebral | 2 | 2001 | 622 | 0.040 |
Why?
|
Motor Cortex | 2 | 2005 | 995 | 0.040 |
Why?
|
Verbal Learning | 1 | 2002 | 462 | 0.040 |
Why?
|
Case-Control Studies | 5 | 2017 | 22053 | 0.040 |
Why?
|
Patient Selection | 2 | 2010 | 4283 | 0.040 |
Why?
|
GABA Modulators | 1 | 1999 | 109 | 0.040 |
Why?
|
Acetazolamide | 1 | 1999 | 96 | 0.040 |
Why?
|
Cerebral Arterial Diseases | 1 | 1999 | 82 | 0.040 |
Why?
|
Evoked Potentials, Visual | 1 | 2002 | 415 | 0.040 |
Why?
|
Treatment Outcome | 5 | 2021 | 65017 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2017 | 20509 | 0.040 |
Why?
|
Antiviral Agents | 1 | 2011 | 3061 | 0.040 |
Why?
|
Pattern Recognition, Automated | 2 | 2018 | 994 | 0.040 |
Why?
|
Tissue Plasminogen Activator | 1 | 2005 | 1190 | 0.040 |
Why?
|
Blood Glucose | 1 | 2013 | 6381 | 0.040 |
Why?
|
Nevus | 1 | 2000 | 205 | 0.040 |
Why?
|
Inflammation | 1 | 2018 | 10756 | 0.040 |
Why?
|
Endarterectomy, Carotid | 1 | 2004 | 564 | 0.040 |
Why?
|
Antipsychotic Agents | 1 | 2012 | 3061 | 0.040 |
Why?
|
Cohort Studies | 5 | 2019 | 41335 | 0.040 |
Why?
|
Inositol | 2 | 2011 | 215 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2016 | 9276 | 0.040 |
Why?
|
Aorta | 1 | 2006 | 2039 | 0.040 |
Why?
|
Circadian Rhythm | 1 | 2009 | 2571 | 0.040 |
Why?
|
Incidence | 4 | 2017 | 21392 | 0.040 |
Why?
|
Spectrophotometry, Infrared | 1 | 1997 | 116 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 3334 | 0.040 |
Why?
|
Choline | 2 | 2011 | 513 | 0.040 |
Why?
|
Regression Analysis | 3 | 2015 | 6360 | 0.040 |
Why?
|
ROC Curve | 1 | 2005 | 3568 | 0.040 |
Why?
|
Vibration | 1 | 1999 | 327 | 0.040 |
Why?
|
Anomia | 1 | 1996 | 13 | 0.040 |
Why?
|
Expert Testimony | 1 | 2019 | 361 | 0.040 |
Why?
|
Lymphatic Metastasis | 1 | 2005 | 2943 | 0.030 |
Why?
|
Brain Chemistry | 2 | 2011 | 959 | 0.030 |
Why?
|
Physiology | 1 | 1997 | 112 | 0.030 |
Why?
|
Aspartic Acid | 2 | 2011 | 576 | 0.030 |
Why?
|
Disability Evaluation | 2 | 2016 | 1826 | 0.030 |
Why?
|
Pilot Projects | 4 | 2012 | 8555 | 0.030 |
Why?
|
Hypoxia, Brain | 1 | 1997 | 138 | 0.030 |
Why?
|
Spinal Cord Injuries | 2 | 1994 | 924 | 0.030 |
Why?
|
Retrospective Studies | 6 | 2021 | 80372 | 0.030 |
Why?
|
Reference Standards | 1 | 2019 | 1004 | 0.030 |
Why?
|
Risk Factors | 7 | 2020 | 74359 | 0.030 |
Why?
|
Imagination | 1 | 1997 | 226 | 0.030 |
Why?
|
Sex Characteristics | 2 | 2013 | 2629 | 0.030 |
Why?
|
Oxygen Consumption | 1 | 2002 | 1843 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 11712 | 0.030 |
Why?
|
Prosencephalon | 1 | 1997 | 305 | 0.030 |
Why?
|
Data Interpretation, Statistical | 2 | 2019 | 2696 | 0.030 |
Why?
|
Brain Stem | 1 | 2000 | 857 | 0.030 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 1997 | 397 | 0.030 |
Why?
|
Maze Learning | 1 | 1996 | 477 | 0.030 |
Why?
|
Central Nervous System Diseases | 1 | 1999 | 521 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2019 | 1722 | 0.030 |
Why?
|
Parietal Lobe | 3 | 2005 | 850 | 0.030 |
Why?
|
Prefrontal Cortex | 3 | 2006 | 2212 | 0.030 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2016 | 280 | 0.030 |
Why?
|
Activities of Daily Living | 2 | 2016 | 2417 | 0.030 |
Why?
|
Vaccines, Attenuated | 1 | 1995 | 314 | 0.030 |
Why?
|
Dendrites | 1 | 1996 | 475 | 0.030 |
Why?
|
Embolism | 1 | 1997 | 408 | 0.030 |
Why?
|
Statistics, Nonparametric | 3 | 2011 | 2852 | 0.030 |
Why?
|
Tomography, Emission-Computed | 3 | 2001 | 1121 | 0.030 |
Why?
|
Disease Models, Animal | 4 | 2022 | 18137 | 0.030 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2008 | 3701 | 0.030 |
Why?
|
Europe | 1 | 2019 | 3441 | 0.030 |
Why?
|
Bone Neoplasms | 1 | 2005 | 2532 | 0.030 |
Why?
|
Intracranial Arteriovenous Malformations | 1 | 1996 | 367 | 0.030 |
Why?
|
Equipment Design | 2 | 1998 | 3520 | 0.030 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2015 | 436 | 0.030 |
Why?
|
Predictive Value of Tests | 4 | 2016 | 15289 | 0.030 |
Why?
|
Melanoma, Experimental | 1 | 1995 | 562 | 0.020 |
Why?
|
Language Tests | 2 | 2002 | 190 | 0.020 |
Why?
|
Hunger | 1 | 2013 | 206 | 0.020 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2020 | 2418 | 0.020 |
Why?
|
Postprandial Period | 1 | 2013 | 315 | 0.020 |
Why?
|
Essential Tremor | 1 | 2014 | 157 | 0.020 |
Why?
|
Neoplasm Metastasis | 2 | 2015 | 4902 | 0.020 |
Why?
|
Dopamine Antagonists | 1 | 2012 | 288 | 0.020 |
Why?
|
Alcoholic Intoxication | 1 | 2012 | 174 | 0.020 |
Why?
|
Obesity | 1 | 2013 | 12922 | 0.020 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2013 | 321 | 0.020 |
Why?
|
Oxygen Radioisotopes | 1 | 2010 | 75 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2017 | 12159 | 0.020 |
Why?
|
Mental Status Schedule | 1 | 2011 | 314 | 0.020 |
Why?
|
Encephalitis | 1 | 2014 | 437 | 0.020 |
Why?
|
Hypertension | 1 | 2010 | 8594 | 0.020 |
Why?
|
Imidazoles | 1 | 2016 | 1180 | 0.020 |
Why?
|
Thalamus | 1 | 1996 | 1041 | 0.020 |
Why?
|
Viral Vaccines | 1 | 1995 | 596 | 0.020 |
Why?
|
Herpesvirus 1, Human | 1 | 1995 | 753 | 0.020 |
Why?
|
Ribavirin | 1 | 2011 | 396 | 0.020 |
Why?
|
Psychomotor Agitation | 1 | 2012 | 305 | 0.020 |
Why?
|
Receptors, Dopamine D2 | 1 | 2012 | 485 | 0.020 |
Why?
|
Creatine | 1 | 2011 | 426 | 0.020 |
Why?
|
Dopamine Agonists | 1 | 2012 | 352 | 0.020 |
Why?
|
Nerve Fibers, Unmyelinated | 1 | 2009 | 97 | 0.020 |
Why?
|
Choroid | 1 | 2011 | 349 | 0.020 |
Why?
|
Area Under Curve | 1 | 2013 | 1636 | 0.020 |
Why?
|
Cerebrum | 1 | 2010 | 132 | 0.020 |
Why?
|
Behavior | 2 | 2002 | 540 | 0.020 |
Why?
|
Sleep | 1 | 2005 | 4751 | 0.020 |
Why?
|
Electrodes | 1 | 2011 | 614 | 0.020 |
Why?
|
Pitch Perception | 1 | 2009 | 101 | 0.020 |
Why?
|
Health Status | 1 | 2002 | 4081 | 0.020 |
Why?
|
Molecular Imaging | 1 | 2015 | 818 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6498 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2020 | 3301 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2011 | 1705 | 0.020 |
Why?
|
Autonomic Nervous System | 1 | 2013 | 697 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 2 | 1996 | 8158 | 0.020 |
Why?
|
Double-Blind Method | 2 | 2012 | 12427 | 0.020 |
Why?
|
Interferons | 1 | 2011 | 705 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2019 | 3484 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2011 | 940 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2011 | 10827 | 0.020 |
Why?
|
Linear Models | 2 | 2009 | 5877 | 0.020 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2009 | 252 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2016 | 3735 | 0.020 |
Why?
|
Child | 6 | 2017 | 79806 | 0.020 |
Why?
|
Phlebotomy | 1 | 2008 | 137 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2010 | 2007 | 0.020 |
Why?
|
Microvessels | 1 | 2011 | 572 | 0.020 |
Why?
|
Feedback, Physiological | 1 | 2010 | 476 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2011 | 2014 | 0.020 |
Why?
|
Orthopedic Procedures | 1 | 2017 | 1263 | 0.020 |
Why?
|
Carbon Dioxide | 1 | 2011 | 1146 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2015 | 9411 | 0.020 |
Why?
|
Hyperventilation | 1 | 2007 | 79 | 0.020 |
Why?
|
Tectum Mesencephali | 1 | 2006 | 18 | 0.020 |
Why?
|
HIV Seropositivity | 1 | 2012 | 955 | 0.020 |
Why?
|
Safety | 1 | 2011 | 1148 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2013 | 10446 | 0.020 |
Why?
|
Spinal Puncture | 1 | 2008 | 281 | 0.020 |
Why?
|
Periaqueductal Gray | 1 | 2007 | 110 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2019 | 3539 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2015 | 1741 | 0.020 |
Why?
|
Expressed Emotion | 1 | 2006 | 92 | 0.020 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2011 | 893 | 0.020 |
Why?
|
Cholinergic Antagonists | 1 | 2006 | 164 | 0.020 |
Why?
|
Polyethylene Glycols | 1 | 2011 | 1189 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2016 | 6015 | 0.020 |
Why?
|
Least-Squares Analysis | 1 | 2006 | 369 | 0.020 |
Why?
|
Up-Regulation | 1 | 2015 | 4122 | 0.020 |
Why?
|
Lactates | 1 | 2006 | 404 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2011 | 1257 | 0.020 |
Why?
|
Diffusion | 2 | 2000 | 813 | 0.020 |
Why?
|
Interview, Psychological | 1 | 2008 | 810 | 0.020 |
Why?
|
Models, Animal | 1 | 2011 | 2117 | 0.020 |
Why?
|
Electroencephalography | 3 | 2012 | 6189 | 0.020 |
Why?
|
Middle Cerebral Artery | 1 | 2006 | 276 | 0.020 |
Why?
|
Comorbidity | 1 | 2019 | 10551 | 0.010 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2006 | 281 | 0.010 |
Why?
|
Kidney Transplantation | 1 | 2019 | 4215 | 0.010 |
Why?
|
Acetylcholine | 1 | 2006 | 629 | 0.010 |
Why?
|
Child, Preschool | 4 | 2012 | 42063 | 0.010 |
Why?
|
Thoracic Vertebrae | 1 | 2009 | 597 | 0.010 |
Why?
|
Gait | 1 | 2009 | 812 | 0.010 |
Why?
|
Software | 1 | 2018 | 4419 | 0.010 |
Why?
|
Schizophrenia | 1 | 2002 | 6915 | 0.010 |
Why?
|
Occipital Lobe | 1 | 2005 | 373 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2011 | 4899 | 0.010 |
Why?
|
Risk Assessment | 2 | 2017 | 24123 | 0.010 |
Why?
|
Length of Stay | 1 | 2017 | 6479 | 0.010 |
Why?
|
Syndrome | 1 | 2009 | 3280 | 0.010 |
Why?
|
Blotting, Western | 1 | 2010 | 5039 | 0.010 |
Why?
|
Cervical Vertebrae | 1 | 2009 | 978 | 0.010 |
Why?
|
Linguistics | 1 | 2003 | 106 | 0.010 |
Why?
|
Logistic Models | 1 | 2017 | 13314 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15687 | 0.010 |
Why?
|
Paired-Associate Learning | 1 | 2002 | 53 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2010 | 2379 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2012 | 2754 | 0.010 |
Why?
|
Qualitative Research | 1 | 2012 | 2963 | 0.010 |
Why?
|
Serotonin | 1 | 2006 | 1040 | 0.010 |
Why?
|
Walking | 1 | 2009 | 1189 | 0.010 |
Why?
|
Heart Rate | 1 | 2013 | 4179 | 0.010 |
Why?
|
Visual Perception | 1 | 2010 | 1374 | 0.010 |
Why?
|
Melatonin | 1 | 2006 | 668 | 0.010 |
Why?
|
Happiness | 1 | 2002 | 170 | 0.010 |
Why?
|
Glutamic Acid | 1 | 2006 | 1167 | 0.010 |
Why?
|
Judgment | 1 | 2003 | 273 | 0.010 |
Why?
|
Acute Disease | 2 | 2003 | 7269 | 0.010 |
Why?
|
Information Storage and Retrieval | 1 | 2006 | 822 | 0.010 |
Why?
|
Amino Acids | 1 | 2006 | 1714 | 0.010 |
Why?
|
Age Factors | 1 | 2017 | 18416 | 0.010 |
Why?
|
Limbic System | 1 | 2003 | 419 | 0.010 |
Why?
|
Genetic Markers | 1 | 2006 | 2608 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2010 | 2634 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2010 | 2062 | 0.010 |
Why?
|
Anger | 1 | 2002 | 401 | 0.010 |
Why?
|
Electrocardiography | 1 | 2013 | 6414 | 0.010 |
Why?
|
Drug Administration Routes | 1 | 1999 | 150 | 0.010 |
Why?
|
Stimulation, Chemical | 1 | 1999 | 306 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 2010 | 2628 | 0.010 |
Why?
|
Semantics | 1 | 2003 | 599 | 0.010 |
Why?
|
Mathematics | 1 | 2000 | 707 | 0.010 |
Why?
|
Models, Psychological | 1 | 2003 | 827 | 0.010 |
Why?
|
Random Allocation | 1 | 2003 | 2394 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 12960 | 0.010 |
Why?
|
Health Surveys | 1 | 2008 | 4063 | 0.010 |
Why?
|
Olfactory Pathways | 1 | 1999 | 132 | 0.010 |
Why?
|
Wakefulness | 1 | 2005 | 1255 | 0.010 |
Why?
|
Organ Specificity | 1 | 2002 | 1955 | 0.010 |
Why?
|
Speech | 1 | 2002 | 550 | 0.010 |
Why?
|
Databases, Factual | 1 | 2012 | 8035 | 0.010 |
Why?
|
Smell | 1 | 1999 | 259 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2010 | 11071 | 0.010 |
Why?
|
Hospitalization | 1 | 2016 | 10790 | 0.010 |
Why?
|
Thalamic Nuclei | 1 | 1996 | 111 | 0.010 |
Why?
|
Postoperative Period | 1 | 2001 | 1818 | 0.010 |
Why?
|
Schizophrenic Psychology | 1 | 2002 | 1646 | 0.010 |
Why?
|
Computer Graphics | 1 | 1996 | 341 | 0.010 |
Why?
|
Copper Sulfate | 1 | 1994 | 13 | 0.010 |
Why?
|
Postpartum Period | 1 | 2001 | 1167 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2008 | 3164 | 0.010 |
Why?
|
Models, Structural | 1 | 1994 | 341 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2007 | 3150 | 0.010 |
Why?
|
Contusions | 1 | 1994 | 79 | 0.010 |
Why?
|
Fear | 1 | 2002 | 1462 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2013 | 15789 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 1997 | 1900 | 0.010 |
Why?
|
Postoperative Care | 1 | 1999 | 1479 | 0.010 |
Why?
|
Biomedical Research | 1 | 2008 | 3426 | 0.010 |
Why?
|
Hematoma | 1 | 1997 | 769 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2012 | 26181 | 0.010 |
Why?
|
Cricetinae | 1 | 1995 | 2427 | 0.010 |
Why?
|
Copper | 1 | 1994 | 368 | 0.010 |
Why?
|
United States | 1 | 2019 | 72461 | 0.010 |
Why?
|
Antigens, Viral | 1 | 1995 | 980 | 0.010 |
Why?
|
Phenotype | 1 | 2009 | 16546 | 0.010 |
Why?
|
Surface Properties | 1 | 1994 | 1161 | 0.010 |
Why?
|
Video Recording | 1 | 1995 | 955 | 0.010 |
Why?
|
Swine | 1 | 2000 | 5899 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2001 | 2869 | 0.010 |
Why?
|
Mental Disorders | 1 | 2010 | 6796 | 0.010 |
Why?
|
Edema | 1 | 1994 | 769 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 1995 | 1784 | 0.000 |
Why?
|
Prostheses and Implants | 1 | 1994 | 1273 | 0.000 |
Why?
|
Sex Factors | 1 | 2000 | 10547 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 2001 | 12965 | 0.000 |
Why?
|
Cerebral Hemorrhage | 1 | 1997 | 2660 | 0.000 |
Why?
|
Infant | 1 | 2007 | 36060 | 0.000 |
Why?
|
Epilepsy | 1 | 2000 | 3267 | 0.000 |
Why?
|
Gene Expression | 1 | 1997 | 7588 | 0.000 |
Why?
|
RNA, Messenger | 1 | 1997 | 12766 | 0.000 |
Why?
|
Cell Line | 1 | 1995 | 15620 | 0.000 |
Why?
|